Rosacea Treatment Market

Rosacea Treatment Market: Introduction

• Rosacea is a skin condition that makes the blood vessels visible and turns a person’s skin red. It also causes tiny, red, pus-filled bumps on the skin. Commonly found among middle-aged women, it is often mistaken for allergies, acne, or other skin infections.
• Rosacea is a skin condition characterized by redness and visible blood vessels on the face. Nose and cheeks are the affected regions of the body. The symptoms of rosacea are small, red, pus-filled bumps that could flare up periodically. Around half of rosacea patients experience eye dryness, irritation, and swollen, reddened eyelids. Other symptoms include thickening of skin on the nose, (rhinophyma), and enlarged nose. Rosacea primarily affects middle-aged women having fair skin.
• Patents of several branded medicines used to treat rosacea are expiring and pharmaceutical companies are introducing generic versions. This boosts the growth of the global rosacea treatment market.

Key Drivers, Restraints, and Opportunities of Global Rosacea Treatment Market

• Rise in the availability of generic medicines for rosacea is a major driver of the global rosacea treatment market. Patents of a number of branded drugs either have expired or are awaiting expiry. Prominent drug makers have already commenced manufacturing generic substitutes for the existing branded drugs.
• Generic drugs are comparatively cheaper than the branded options. This fuels the global rosacea treatment market. It also presents opportunities for pharmaceutical players across different regions to develop their own off-label brand.
• A number of doctors prescribe acne medications to cure rosacea. Most treatment options for rosacea are either oral or topical; however, there is a push toward developing innovative ways. This will increase the efficiency of the treatment, and is a growing trend in the global rosacea treatment market.
• The generic drug pipeline for rosacea treatment has led to the launch of new products. However, a number of pharmaceutical companies are working on launch of patented drugs. This is projected to augment the global rosacea treatment market.
• Rosacea is common among fair-skinned people. Studies have found that more than 400 million people across the world suffer from rosacea. This is a key trend in the global rosacea treatment market.
• Development of several new treatment options drives the global market. However, low diagnosis despite high prevalence acts as a major restraint of the global rosacea treatment market. However, efforts from government and other stakeholders is expected to overcome this challenge.

North America to Capture Major Share of Global Rosacea Treatment Market

Geographically, the global rosacea treatment market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to lead the global rosacea treatment market during the forecast period due to high awareness among the population, dominant pharmaceutical market, and timely diagnosis. The market in Europe is anticipated grow at a steady pace from 2021 to 2031. The rosacea treatment market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Improvement in health care infrastructure, rise in awareness, and high per capita income propel the market in the region. Developing countries such as India and China are likely to be major markets in Asia Pacific.

Key Players Operating in Global Rosacea Treatment Market

The global rosacea treatment market is highly fragmented due to the presence of large number of key players. These players hold major market share in their respective regions. Existing players are entering into partnerships to expand global footprint. At the same time, companies are increasing their R&D investments to identify better treatments for rosacea. Major players operating in the global rosacea treatment market are:

• Bayer Schering AG
• Allergen plc
• Bausch Health Companies, Inc.
• Oamix Pharmaceuticals Ltd.
• Sonoma Pharmaceuticals, Inc.
• Pfizer, Inc.
• Nestlé Skin Health (Galderma S.A.)
• Bayer AG
• Mylan N.V.
• Janssen Pharmaceuticals, Inc.
• Teva Pharmaceuticals Company
• Aclaris Therapeutics
• Leo Pharma, Inc.
• Hovione FarmaCiencia SA
• Nestlé (Galderma)
• Others

Global Rosacea Treatment Market: Research Scope

Global Rosacea Treatment Market, by Drug Class

• Alpha Agonists
• Antibiotics
• Corticosteroids
• Retinoid
• Immunosuppressant
• Antihypertensive Agents
• Others

Global Rosacea Treatment Market, by Mode of Administration

• Oral
• Topical

Global Rosacea Treatment Market, by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies & Drugstores
• Online Sales

Global Rosacea Treatment Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa